Bayer application for regulatory approval of Aflibercept 8 mg accepted in China Ruchika Sharma26 Jan 2024 4:00 PM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) accepted the...
Bayer Eylea 8 mg gets Japanese marketing nod Ruchika Sharma21 Jan 2024 1:00 PM ISTBerlin: Bayer has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg...
Roche gets CDSCO panel Nod To study safety, and efficacy of Faricimab Intravitreal injection Dr. Divya Colin29 Oct 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Brolucizumab treatment associated with visual acuity improvement for neovascular age-related macular degeneration Dr Ishan Kataria8 Oct 2023 8:00 PM ISTBrolucizumab is a low molecular weight humanized antibody fragment as a vascular endothelial growth factor (VEGF) inhibitor. Registered Phase III...
Submit interim analysis results of study in Russia and India: CDSCO panel Tells Lupin Over Aflibercept Dr. Divya Colin28 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal to enroll an additional 298 patients from India in the study of the ophthalmic drug Aflibercept, the Subject...
Zydus Lifescience Gets CDSCO Panel Nod to Study Aflibercept Dr. Divya Colin7 Jun 2023 6:00 PM ISTNew Delhi: The drug major Zydus Lifescience has got the green signal from the Subject Expert Committee SEC functional under Central Drug Standard...
Levodopa Use Tied to Reduced Incidence of neovascular age-related macular degeneration Aditi1 Jun 2023 2:30 AM ISTPrevious studies have mentioned that Levodopa is tied to reduced development of new-onset neovascular age-related macular degeneration (nAMD).Data has...
Retinal venular vasculature may predict initial treatment response to intravitreal therapy Aditi23 May 2023 8:00 PM ISTDenmark: A research article published in Acta Ophthalmologica, a study has demonstrated that retinal venular vasculature may predict the initial...
Lupin gets CDSCO panel nod to study Ranibizumab Dr. Divya Colin7 March 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got the green signal from the Subject Expert Committee (SEC) from the Central Drug Standard Control Organisation...
Roche gets CDSCO Panel nod to import, market ophthalmic drug Faricimab solution Dr. Divya Colin6 March 2023 6:00 PM ISTNew Delhi: Granting the request for waiver of Phase III clinical trial of Faricimab 6mg/0.05mL solution for Intravitreal Injection in the country, the...
Bayer submits Aflibercept 8 mg for regulatory approval in two major retinal eye diseases in EU Ruchika Sharma7 Feb 2023 2:15 PM ISTAflibercept 8 mg is being jointly developed by Bayer and Regeneron.
Intravitreal Faricimab improves visual and anatomic outcomes for Aflibercept-Resistant nAMD Dr Ishan Kataria2 Jan 2023 9:45 AM ISTIntravitreal therapies neutralizing vascular endothelial growth factor (VEGF) have considerably reduced the extent of vision loss in patients with...
